1-4 of 4
Adriana Scheliga, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

AUGMENT: A Phase III Randomized Study of Lenalidomide Plus Rituximab (R 2 ) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

John P. Leonard, MD, Marek Trněný, Koji Izutsu, MDPhD, Nathan H. Fowler, MD, Xiaonan Hong, MD, Jun Zhu, Huilai Zhang, MDPhD, Fritz Offner, MD, Adriana Scheliga, MD, Grzegorz S. Nowakowski, MD, Antonio Pinto, MD, Francesca Re, MDPhD, Laura Maria Fogliatto, MD, Phillip Scheinberg, MD, Ian W. Flinn, MD PhD, Cláudia Moreira, MD, David Liu, MDPhD, Stacey Kalambakas, MD, Pierre Fustier, PhD, Chengqing Wu, PhD, John G. Gribben
Journal: Blood
Blood (2018) 132 (Supplement 1): 445.
https://doi.org/10.1182/blood-2018-99-110861
Published: 2018
Journal Articles

Identification of Patient Subgroups Demonstrating Longer Progression-Free Survival (PFS) Benefit with Bortezomib-Rituximab Versus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma (FL): Biomarker Analyses of the Phase 3 LYM3001 Study

Bertrand Coiffier, MD, Weimin Li, Erin D Henitz, BS, J. D. Karkera, PhD, Reyna Favis, PhD, Dana Gaffney, MS, Alice Shapiro, MS, Panteli Theocharous, BSc (hons), MSc, PhD, Yusri A Elsayed, MD, PhD, Helgi van de Velde, MD, PhD, Evgenii A Osmanov, MD, PhD, Xiaonan Hong, MD, Adriana Scheliga, MD, Fritz C. Offner, MD, PhD, Simon Rule, Adriana C Teixeira, MD, Jan Walewski, MD, PhD, Sven de Vos, MD, PhD, Michael Crump, MD, FRCPC, Ofer Shpilberg, MD, MPH, Pier Luigi Zinzani, MD, PhD, Andrew Z Cakana, MD, FRCPath, Dixie-Lee Esseltine, MD, FRCPC, George Mulligan, PhD, Deborah S Ricci, PhD
Journal: Blood
Blood (2011) 118 (21): 265.
https://doi.org/10.1182/blood.V118.21.265.265
Published: 2011
Journal Articles

A Phase 3 Trial Comparing Bortezomib Plus Rituximab with Rituximab Alone In Patients with Relapsed, Rituximab-Naive or -Sensitive, Follicular Lymphoma

Bertrand Coiffier, MD, PhD, Evgenii Osmanov, MD, Xiaonan Hong, MD, Adriana Scheliga, MD, Jiri Mayer, MD, PhD, Fritz C Offner, MD, PhD, Simon A. Rule, MD, Adriana Teixeira, MD, Jan A Walewski, MD, PhD, DSc, Michael Crump, MD, FRCPC, Ofer Shpilberg, MD, MPH, Robert Hermann, MD, Sudha Parasuraman, MD, Eugene Zhu, PhD, Christopher Enny, BS, Panteli Theocharous, MSc, PhD, Helgi van de Velde, MD, PhD, Yusri Elsayed, MD, PhD, Pier Luigi Zinzani, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 857.
https://doi.org/10.1182/blood.V116.21.857.857
Published: 2010
Journal Articles

The Expression of Protein Kinase C Beta II (PKCβ) by Immunocytochemistry Is Predictive of the Disease Free Survival (DFS) in Diffuse Large B-Cell Lymphoma (DLBCL).

Rony Schaffel, MD, Irene Biasoli, MD, Adriana Scheliga, MD, Jose C. Morais, PhD, Sergio Romano, MD, Wolmar Pulcheri, MD, Nelson Spector, PhD
Journal: Blood
Blood (2004) 104 (11): 4561.
https://doi.org/10.1182/blood.V104.11.4561.4561
Published: 2004